STALEVO 7518.75200

Држава: Израел

Језик: Енглески

Извор: Ministry of Health

Купи Сада

Активни састојак:

CARBIDOPA AS MONOHYDRATE; ENTACAPONE; LEVODOPA

Доступно од:

INOVAMED PHARMA LTD, ISRAEL

АТЦ код:

N04BA01

Фармацеутски облик:

FILM COATED TABLETS

Састав:

CARBIDOPA AS MONOHYDRATE 18.75 MG; ENTACAPONE 200 MG; LEVODOPA 75 MG

Пут администрације:

PER OS

Тип рецептора:

Required

Произведен од:

ORION CORPORATION ORION PHARMA,FINLAND

Терапеутска област:

LEVODOPA

Терапеутске индикације:

Treatment of patients with Parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa/decarboxylase (DDC) inhibitor treatment.

Датум одобрења:

2016-07-24

Информативни летак

                                STAL CTAB PL SH 290920
STAL CTAB PL SH 290920
PATIENT PACKAGE INSERT
IN ACCORDANCE WITH THE
PHARMACISTS’ REGULATIONS
)PREPARATIONS( – 1986
THE MEDICINE IS DISPENSED WITH A
DOCTOR’S PRESCRIPTION ONLY
STALEVO
®
50/12.5/200 MG
Film-coated tablets
STALEVO
®
75/18.75/200 MG
Film-coated tablets
STALEVO
®
100/25/200 MG
Film-coated tablets
STALEVO
®
125/31.25/200 MG
Film-coated tablets
STALEVO
®
150/37.5/200 MG
Film-coated tablets
STALEVO
®
200/50/200 MG
Film-coated tablets
ACTIVE INGREDIENTS
Stalevo 50/12.5/200 mg
Each
tablet
contains
levodopa/
carbidopa/entacapone
50/12.5/200 mg
Stalevo 75/18.75/200 mg
Each
tablet
contains
levodopa/
carbidopa/entacapone
75/18.75/200 mg
Stalevo 100/25/200 mg
Each
tablet
contains
levodopa/
carbidopa/entacapone
100/25/200 mg
Stalevo 125/31.25/200 mg
Each
tablet
contains
levodopa/
carbidopa/entacapone
125/31.25/200 mg
Stalevo 150/37.5/200 mg
Each
tablet
contains
levodopa/
carbidopa/entacapone
150/37.5/200 mg
Stalevo 200/50/200 mg
Each
tablet
contains
levodopa/
carbidopa/entacapone
200/50/200 mg
INACTIVE INGREDIENTS
See section 6 ‘Further Information’ and
section 2 ‘Before using the medicine’
in section ‘Important information
about some of the ingredients of the
medicine’.
READ THE LEAFLET CAREFULLY IN ITS
ENTIRETY BEFORE USING THE MEDICINE.
This leaflet contains concise information
about the medicine. If you have further
questions, refer to the doctor or
pharmacist.
This medicine has been prescribed
to treat your ailment. Do not pass it
on to others. It may harm them even
if it seems to you that their ailment is
similar.
1. WHAT
IS
THE
MEDICINE
INTENDED FOR?
For treatment of Parkinson’s disease.
THERAPEUTIC GROUP: Anti-Parkinson
medicines, dopa and dopa derivatives.
Stalevo contains 3 active ingredients
)levodopa, carbidopa and entacapone(
in one film-coated tablet. Parkinson’s
disease is caused by low brain levels
of a substance called dopamine.
Levodopa
increases
the
amount
of dopamine, thereby reducing the
symptoms of Parkinson’s disease.
Carbidopa and enta
                                
                                Прочитајте комплетан документ
                                
                            

Карактеристике производа

                                [לוגו מדינת ישראל] [http://www.gov.il/]
[http://www.gov.il/] [לוגו משרד הבריאות] [לוגו משרד
הבריאות] [*5400]
[http://www.health.gov.il/PniyotHazibur/Pages/CallCenter.aspx]
[http://www.health.gov.il/PniyotHazibur/Pages/CallCenter.aspx]
הציבור הרחב עסקים ומוסדות עובדים
בבריאות חפש מידע
תפריט	*
[סגירה]
סגור	*
דף הבית [http://www.health.gov.il/]	*
אודות	*
אודות המשרד
[http://www.health.gov.il/About/Pages/about_us.aspx]	*
תוכנית עבודה
[http://www.health.gov.il/About/Pages/Agenda.aspx]	*
תקציב המשרד
[http://www.health.gov.il/About/Pages/budget.aspx]	*
תרשים מבנה ארגוני
[http://www.health.gov.il/About/Pages/OrganizationalStructureDiagram.aspx]	*
בעלי תפקידים
[http://www.health.gov.il/About/Phonebook/Pages/PhoneBook.aspx]	*
יחידות המשרד
[http://www.health.gov.il/UnitsOffice/Pages/UnitsList.aspx]	*
לשכות הבריאות
[http://www.health.gov.il/About/Phonebook/Pages/PhoneBook.aspx?tab=3]	*
אמנת שירות
[http://www.health.gov.il/About/sla/Pages/default.aspx]	*
אותות ופרסים
[http://www.health.gov.il/About/Awards/Pages/mifal.aspx]	*
פרוייקטים תשתיתיים
[http://www.health.gov.il/About/projects/shared_medical_info/Pages/default.aspx]	*
דרושים
[http://www.health.gov.il/About/Careers/Pages/default.aspx]	*
מנכ"לי משרד הבריאות לדורותיהם
[http://www.health.gov.il/About/Pages/GeneralManegerHistory.aspx]	*
יחידות המשרד	*
יחידות המשרד
[http://www.health.gov.il/UnitsOffice/Pages/UnitsList.aspx]	*
לשכות הבריאות
[http://www.health.gov.il/UnitsOffice/LB/Pages/default.aspx]	*
וועדות ומועצות
[http://www.health.gov.il/Services/Committee/Pages/CommitteeList.aspx]	*
נושאים	*
בריאות הנפש
[http://www.health.gov.il/Subjects/mental_health/Pages/default.aspx]	*
בריאות הסביבה
[http://www.health.gov.il/Subjects/Environmental_Health/
                                
                                Прочитајте комплетан документ
                                
                            

Документи на другим језицима

Информативни летак Информативни летак Арапски 02-11-2020
Информативни летак Информативни летак Хебрејски 02-11-2020

Обавештења о претрази у вези са овим производом

Погледајте историју докумената